A study on Applications of prescriptions including Rhizoma Anemarrhenae as a main component in Dongeuibogam

This report describes 68 studies related to the use of Rhizoma Anemarrhenae main blended prescription from Dongeuibogam. The following conclusion were reached through investigations on the prescriptions that use Rhizoma Anemarrhenae as a key ingredient. Prescriptions that Rhizoma Anemarrhenae was taken as a monarch drug are utilized for 21 therapeutic purposes, for example, cough, malaria, Sang Han syndromes and eye disease. In particular, 22.1% of prescriptions appear in the chapter of cough, and 13.2% of those appear in the chapter of malaria. Prescriptions that utilize Rhizoma Anemarrhenae as the main ingredient are used in the treatment of cough, asthma and malaria. Rhizoma Anemarrhenae is used in pathogenic factors such as fire, and used in pathology related to kidny system. The dosage of Rhizoma Anemarrhenae is 3bun(about 1.12 gram) to 3jeon(about 11.25 gram), however 1jeon(about 3.75 gram) has been taken the most for clinical application. Gamlihuan is the most useful base prescription which use the Rhizoma Anemarrhenae as the main ingredient.